Ledger.Open graph →
SEC Form D · filed October 2, 2023

Atsena Therapeutics, Inc

Offering
$32.0M
Sold
$24.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Christina Isacson · Durham, NCDirectorPatrick Ritschel · Durham, NCExec · DirectorJacqueline Grant · Durham, NCDirectorJennifer Wellman · Durham, NCDirectorMichael Dial · Boston, MADirectorShannon Boye · Durham, NCDirectorJames Healy · Newtown Square, PADirectorChristina Isacson · Durham, NCDirectorJacqueline Grant · Durham, NCDirectorPatrick Ritschel · Durham, NCExec · DirectorJennifer Wellman · Durham, NCDirectorElizabeth Leiderman · Durham, NCExecMatthew Romney · Salt Lake City, UTDirectorCraig Murli · EMERYVILLE, CADirectorGabriel K. Segal · VANCOUVER, British Columbia, CanadaExec · DirectorJudson K. Lacapra · VANCOUVER, British Columbia, CanadaDirectorMichael Dial · Greenville, NCDirectorShannon Boye · Durham, NCDirectorElizabeth Leiderman · Durham, NCExecJames Healy · West Lebanon, NHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗